Clinical guidelines & publications library
Guidance and publications produced by the RANZCP. Filter by type, topic, date or category.
-
Therapeutic use of medicinal cannabis products
Cannabis, Ethics, Professionalism
Information for psychiatrists about the therapeutic use of medicinal cannabis products, including in psychiatric practice. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2026
- Published in Australia
-
Guidance for authorised prescribers of MDMA and psilocybin
Psychedelics
To provide guidance to psychiatrists following the Therapeutic Goods Administration’s (TGA) May 2026 recommendations regarding access to 3,4-methylenedioxy-methamphetamine (MDMA) and psilocybin for the purpose of psychedelic-assisted therapy (PAT). PDF Clinical guideline
Clinical guideline- Last updated: May 2026
-
Psychedelic training framework for psychiatrists
Psychedelics
Information for psychiatrists about psychedelic-assisted therapy with MDMA and psilocybin.
Clinical guideline- Last updated: Jun 2025
- Published in Australia
-
Medical benefits for psychiatric treatment and training
Medicare, Professionalism
Professional Practice Guideline 1: Medical benefits for psychiatric treatment and training was rescinded in May 2025.
Clinical guideline- Last updated: May 2025
- Published in Australia
- PPG #1
- Rescinded
-
Use of ketamine in psychiatric practice
Ethics, Ketamine, Professionalism
Information for psychiatrists about the potential utility of ketamine in psychiatric practice. PDF Clinical guideline
Clinical guideline- Last updated: Apr 2025
- Published in Australia
- PPG# 24
-
INTEGRATE: International guidelines for the algorithmic treatment of schizophrenia
This resource is regarded as a RANZCP Best Practice Resource (BPR) Supported resource for the treatment of schizophrenia. URL Clinical guideline
Clinical guideline- Last updated: Mar 2025
-
Appropriate use of MDMA-assisted psychotherapy for PTSD
PTSD
This resource is regarded as a RANZCP Best Practice Resource (BPR) Endorsed Clinical Guideline for the appropriate use of Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder. URL Clinical guideline
Clinical guideline- Last updated: Mar 2025
- Published in Australia
- Best Practice Resource: Endorsed Clinical Guideline
-
Valproate in healthcare
Professionalism
The RANZCP has endorsed the following resource produced by the Royal College of Psychiatrists in the United Kingdom. URL Clinical guideline
Clinical guideline- Last updated: Oct 2024
- Published in United Kingdom
- Endorsed External Guideline
-
Pharmacogenetics in healthcare
Ethics, Genetic testing, Professionalism, Culturally safe practice
The RANZCP has endorsed the following resources produced by the Royal College of Pathologists of Australasia. URL Clinical guideline
Clinical guideline- Last updated: Oct 2024
- Published in Australia
- Endorsed external guidance
-
Administration of repetitive transcranial magnetic stimulation (rTMS)
Electroconvulsive therapy & neurostimulation, Ethics, Professionalism
Guidance on key professional practice issues that psychiatrists should consider when prescribing and administering repetitive transcranial magnetic stimulation (rTMS). PDF Clinical guideline
Clinical guideline- Last updated: May 2024
- Published in Australia
- PPG #16
-
National codes and standards relevant to psychiatry practice and mental health services in Australia and New Zealand
Ethics, Health service standards, Professionalism, Addressing health inequity, Culturally safe practice
Professional Practice Guideline 14 was rescinded in May 2024. PDF Clinical guideline
Clinical guideline- Last updated: May 2024
- Published in Australia
- PPG #14
- Rescinded
-
AADPA Australian Evidence-Based Clinical Practice Guideline for ADHD
ADHD, Professionalism
RANZCP has endorsed the following guideline published by the Australasian ADHD Professionals Association. URL Clinical guideline
Clinical guideline- Last updated: Apr 2024
- Published in Australia
- Endorsed external guideline
-
Off-label prescribing in psychiatry
Ethics, Off-label prescribing, Professionalism
The Royal Australian New Zealand College of Psychiatrists (RANZCP) has developed this
guidance to provide advice to psychiatrists who may be considering the use of medications ‘off label’, with a key focus on risk identification and justification. PDF Clinical guidelineClinical guideline- Last updated: Dec 2023
- Published in Australia
- PPG #4
-
Firearm risk assessments
Ethics, Professionalism, Addressing health inequity
Guidance for psychiatrists in assessing the risk posed by a person's access to firearms.
Clinical guideline- Last updated: Sep 2023
- Published in Australia
- PPG #23
-
Therapeutic use of MDMA for PTSD and psilocybin for treatment resistant depression
Ethics, Psychedelics, Professionalism
Information for psychiatrists about psychedelic-assisted therapy with MDMA and psilocybin. PDF Clinical guideline
Clinical guideline- Last updated: Jun 2023
- Published in Australia
-
Therapeutic use of psychedelic substances
Psychedelics
Information for psychiatrists about the potential utility of psychedelic substances to assist in treating mental illness. PDF Clinical guideline
Clinical guideline- Last updated: Jun 2023
- Published in Australia
-
Assessment and management of behaviours and psychological symptoms of dementia (BPSD)
Dementia, Ethics, Professionalism, Addressing health inequity
A handbook produced by NSW Health. URL Clinical guideline
Clinical guideline- Last updated: Dec 2022
- Published in NSW
- External endorsed guidance
-
Treating hepatitis C
Ethics, Hepatitis C, Professionalism, Addressing health inequity, Culturally safe practice
Guidance for psychiatrists to facilitate care for people living with mental illness who are living with, or at risk of contracting hepatitis C. PDF Clinical guideline
Clinical guideline- Last updated: Nov 2022
- Published in Australia
- PPG #21
-
rTMS therapy during the COVID-19 pandemic
COVID-19, Electroconvulsive therapy & neurostimulation, Professionalism
PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia
-
ECT treatment during the COVID-19 pandemic
Electroconvulsive therapy & neurostimulation, Professionalism
Considerations and precautions for the delivery of ECT during the pandemic. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia